Skip to main content

Annexon, Inc.

ANNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001528115

In the last 90 days, Annexon, Inc. insiders filed 1 open-market purchase and 0 sales; 216 institutions reported holding it in 13F filings for Q2 2026, worth $1.02B in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding Annexon, Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of ANNX: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders7284+12
Shares47.6M48.3M+778.4K (+1.6%)
Value$292.3M$243.3M−$49.1M (−16.8%)

New holders (16)

Institutions that held Annexon, Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to ANNX in Q4 2022
InstitutionSharesValue% of portfolio
Point72 Asset Management, L.P.750,000$3.88M0.01%
Bank of Montreal65,380$365.0K0.00%
Simplex Trading, LLC44,760$231.0K0.01%
683 Capital Management, LLC32,658$168.8K0.02%
Marshall Wace, LLP28,856$149.2K0.00%
Jane Street Group, LLC23,611$122.1K0.00%
Balyasny Asset Management LLC21,605$111.7K0.00%
Man Group plc21,377$110.5K0.00%
Lighthouse Investment Partners, LLC16,560$85.6K0.02%
Boothbay Fund Management, LLC15,443$79.8K0.00%
Jump Financial, LLC12,120$62.7K0.00%
Mirabella Financial Services LLP11,836$61.2K0.01%
Belvedere Trading LLC8,301$42.9K0.02%
Freedom Wealth Alliance, LLC3,889$20.1K0.03%
Red Tortoise LLC729$3.77K0.00%
Royal Bank of Canada9$00.00%

Sold out (4)

Institutions that held Annexon, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of ANNX in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
UBS Oconnor LLC121,757$752.0K
Bailard, Inc.29,086$180.0K
Occudo Quantitative Strategies LP14,132$87.0K
LMR Partners LLP11,121$69.0K